...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Global Comparison of Stability Testing Parameters and Testing Methods for Finished Herbal Products
【24h】

Global Comparison of Stability Testing Parameters and Testing Methods for Finished Herbal Products

机译:稳定性测试参数的全局比较和成品草药产品的测试方法

获取原文
           

摘要

Quality consistencies of drug products are essential to guarantee expected therapeutic activities, and achieving consistent qualities for herbal products is challenging because of their physicochemical complexities and inherent variabilities. Regulatory authorities worldwide have issued regulations or guidelines for stability testing parameters and testing procedures for herbal products stored in proposed conditions. These testing parameters and methods for finished herbal products are detailed in the guidelines and regulations issued by 5 global authorities and 15 countries, that is, the Association of Southeast Asian Nations (ASEAN), the Eurasian Economic Commission (EEC), the European Medicines Agency (EMA), the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), the World Health Organization (WHO), Australia, Brazil, Canada, China, Egypt, Hong Kong, India, Japan, Kenya, Republic of Korea, the Philippines, Qatar, Switzerland, USA, and Zambia. Physical, chemical, and biological stability tests were compared between different dosage forms, and the testing conditions (temperature and relative humidity) used for long-term, accelerated, or intermediate testing were included in the guidelines and regulations. Comparisons of global regulations and guidelines addressing stability testing are fundamental for the international harmonization of herbal product quality assessments. This review aids understanding of the global situation regarding the testing of herbal product quality with respect to storages.
机译:药品的质量持有量对于保证预期的治疗活动至关重要,并且由于其物理化学复杂性和固有的可变性,因此达到了持续的草药产品质量。全球监管机构已发出稳定性测试参数和储存在拟议条件下的草药产品的测试程序的规定或指南。这些测试参数和成品草本产品的方法详述了5个全球当局和15个国家发布的指南和法规,即东南亚国国家(东盟),欧亚经济委员会(EEC),欧洲医学局(EMA),国际委员会统一的人类使用的药物技术要求(ICH),世界卫生组织(WHO),澳大利亚,巴西,加拿大,中国,埃及,香港,印度,日本,肯尼亚,共和国韩国,菲律宾,卡塔尔,瑞士,美国和赞比亚。在不同剂型之间比较了物理,化学和生物稳定性试验,以及用于长期,加速或中间测试的测试条件(温度和相对湿度)包括在指南和法规中。解决稳定性测试的全球法规和指导方针的比较是草药产品质量评估国际协调的基础。这篇评论援助了解有关议员的草药产品质量的全球局势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号